CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

August 9, 2022 · earnings

NGNE earnings: a negative outcome, -8.0%

On August 9, 2022, Neurogene Inc. reached its earnings. The result was a negative outcome, and the stock moved -8.0% in the window around the event. It had already run -5.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$21.20
1d before
$19.51
Event day
$19.67
1d after
$23.60
5d after

Pre-catalyst setup

-5.4%
30-day run-up
7246%
30-day volatility
0.3×
volume spike